We have presented a three dimensional optical protein chip that fulfills the demanding for point-of-care diagnostics in terms of ease-of-use (one step assay), miniaturization (5 μl). The artful combination of magnetic nanoparticles on chip and total internal reflection imaging (TIRI) technology permits the sensitive and rapid detection of hs-CRP (high-sensitivity C-reactive protein). The whole test was complete within 10 min using "all in one step" assay with a limit of detection of 0.1 ng/mL hs-CRP. The measuring range for hs-CRP could be extended to 10 ng/mL. The chip can also be used to detect more parameters in blood samples.
Introduction
This POCT (point-of-care testing) has the advantages of simple equipment operation, accurate and reliable results, those novel technologies and devices to all visitors with a new concept, namely "A number of measurement results can be obtained in place close to the patients in a very short period of time". POCT is a new field of medical development, achieving the rapid progress with the development of high technology and comprehensive application, conforming to the current, fast-paced work of the people [1] - [5] . The patient can obtain timely diagnosis and treatment.
The development of microfluidic technology provides a new idea and platform for the rapid and high-throughput detection of protein, and greatly reduces the cost of detection. Compared with the traditional analysis method, the microfluidic detection technology has the advantages of high efficiency, fast, less reagent consumption, auto-mation and so on.
Study on POCT microfluidic chip challenged the detection of minimal volume, complex pretreatment samples. 
Materials and Methods

Experimental Materials
A pair of commercially available sandwich anti-CRP monoclonal antibodies (mAb) was purchased from Abzymo Biosciences Co. (Beijing, China). The tracer monoclonal antibody was functionalized with biotin. The Carboxyl Streptavidin Magnetic Particles (500 nm diameter, 0.5% w/v) were purchased from ACME microspheres Co. (Indianapolis, IN, USA). Polylysine (PLL, P4832, Sigma), BSA and other reagents were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA). The buffer solutions were prepared with ultra-pure water. Concentration values stated in this study are used by serial dilutions in PBS buffer.
Experimental Equipment
The Poly-Pico System (PolyPico., Ireland) device was used to precisely and uniformly dispense pL-sized arrayed capture monoclonal antibodies particles. The high precision laser engraving machine DPSS (Suzhou, China) can be used to cut double sided adhesive tape to form the microfluidic channel, and reaction chamber of the chip. The TIRI home made system containing the optics module and the magnetic module was used to take image and collect data.
Fabrication of the 3D Optical Biosensor
The optical chip was composed of a 3D glass bottom board, double-sided adhesive on the micro channel, and cover sheet (Figure 1 ). The basic structure of the micro channel was cut by the laser cutting machine on the double-sided adhesive, and the double-sided adhesive was pasted on the surface of the 3D glass base plate. The trace mAb and capture mAb were immobilized on the top and bottom of the reaction chamber. The chip can be divided into the sample port, reaction and detection zone, time gate and waste reservoir.
Detection Method and Data Analysis Method
The principle of detection of the 3D TIRI optical chip is a one-step sandwich immu- 
Results
Optimization on the Reflection Angle of the 3D Chip
One major aim of the assay development was the capture of the clear images that occurred during one-step sandwich immunoassay. The incidence angle and reflection an- 
Detection of hs-CRP
The standard curves with a dilution series of standard CRP samples by PBS buffer were created. The assay achieved an LOD value of 0.1 ng/mL in standard CRP samples. The linear fits to the curves are shown in Figure 4 . The sensitivity of the assay is sufficient to distinguish hs-CRP levels during 0.1 -10 ng/mL (Figure 4) . To enable the measurement of lower and higher concentrations of CRP, further detection and improvements to the chip system are necessary. The assay required no sample preparation and is therefore easy to handle, which is suitable for POC measurement at the patient.
Conclusion
A new, highly sensitive assay to quantify CRP via a POCT device was developed. The device fulfills all the important characteristics of a POCT application. Our assay has a very short measurement time of less than 10 min, and it requires only a small sample 
